The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

The middle value of all realized prices for an artist's works sold at auction during a given period, providing a clearer representation of typical market values by minimizing the influence of extreme ...